Table 1.
Study characteristic | Number of studies* | ||
---|---|---|---|
Overall | ICU | OR | |
Number of studies, N | 271 | 216 | 55 |
Study design, n/total N (%) | |||
Observational | 163/271 (60%) | 147/216 (68%) | 16/55 (29%) |
RCT | 73/271 (27%) | 39/216 (18%) | 34/55 (62%) |
Nonrandomized trial | 14/271 (5%) | 13/216 (6%) | 1/55 (2%) |
Randomized crossover | 13/271 (5%) | 12/216 (6%) | 1/55 (2%) |
Reanalysis | 8/271 (3%) | 5/216 (2%) | 3/55 (6%) |
Continent of origin,† n/total N (%) | |||
Europe | 139/271 (51%) | 114/216 (53%) | 25/55 (46%) |
Asia | 67/271 (25%) | 46/216 (21%) | 21/55 (38%) |
North America | 38/271 (14%) | 36/216 (17%) | 2/55 (4%) |
South America | 19/271 (7%) | 15/216 (7%) | 4/55 (7%) |
Africa | 10/271 (4%) | 8/216 (4%) | 2/55 (4%) |
Australia/New Zealand | 9/271 (3%) | 8/216 (4%) | 1/55 (2%) |
Time period, n/total N (%) | |||
1970s | 4/271 (2%) | 4/216 (2%) | 0/55 (0%) |
1980s | 12/271 (4%) | 12/216 (6%) | 0/55 (0%) |
1990s | 10/271 (4%) | 10/216 (5%) | 0/55 (0%) |
2000s | 34/271 (13%) | 32/216 (15%) | 2/55 (4%) |
2010s | 100/271 (37%) | 85/216 (39%) | 15/55 (27%) |
2020s | 111/271 (41%) | 73/216 (34%) | 38/55 (69%) |
Patient population,† n/total N (%) | |||
ARDS | 162/271 (60%) | 162/216 (75%) | 0/55 (0%) |
Normal | 46/271 (17%) | 0/216 (0%) | 46/55 (84%) |
Laparoscopic | 30/271 (11%) | 0/216 (0%) | 30/55 (55%) |
COVID-19 | 27/271 (10%) | 27/216 (13%) | 0/55 (0%) |
Obese | 25/271 (9%) | 16/216 (7%) | 9/55 (16%) |
Mixed | 22/271 (8%) | 22/216 (10%) | 0/55 (0%) |
AHRF | 12/271 (4%) | 12/216 (6%) | 0/55 (0%) |
COPD | 10/271 (4%) | 10/216 (5%) | 0/55 (0%) |
Postoperative | 10/271 (4%) | 10/216 (5%) | 0/55 (0%) |
ECMO | 10/271 (4%) | 10/216 (5%) | 0/55 (0%) |
Proned | 6/271 (2%) | 4/216 (2%) | 2/55 (4%) |
Included studies are stratified by overall and study setting
*Percentages are for total studies within given column
†Sum of columns is greater than total as some articles fit more than one category
AHRF = acute hypoxemic respiratory failure; ARDS = acute respiratory distress syndrome; COPD = chronic obstructive pulmonary disease; ECMO = extracorporeal membrane oxygenation; ICU = intensive care unit; OR = operating room; RCT = randomized controlled trial